Healthcare News Memantine Market to Reflect Steady Growth | Page 2

REPORT DESCRIPTION
Memantine Market – Overview
Increasing number of pipeline studies for use of memantine are expected to boost growth of the memantine
market. For instance, in September 2016, Lille University Hospital started phase I clinical study for assessing
the effects of memantine on cognitive behavior of patients associated with Alzheimer’s disease. The study is
estimated to be completed by February 2019.
Furthermore, Suven Life Sciences Limited is undergoing phase II clinical study for the comparative study on
safety and efficacy of SUVN-502 along with memantine HCl and donezepil HCl for treating moderate
Alzheimer’s disease. The study was started in September 2015 and is expected to be completed in May 2019.
Increasing number of expired patents of drugs is a major factor hindering growth of the global memantine
market. For instance, according Merz Pharmaceuticals, a Germany-based company, in October 2018, overall
licensing income during patented period for memantine decreased due to expiration of patent protection in a
majority of markets. For instance, according to Merz Pharmaceuticals, the U.S. licensing income for
memantine declined to US$ 138.07 million in 2017-18 compared to US$ 183.34 million in year 2016.
© Coherent market Insights. All Rights Reserved